BVMFAALR3
Market cap193mUSD
Dec 23, Last price
10.13BRL
1D
0.00%
1Q
-33.79%
Jan 2017
-30.85%
IPO
-43.91%
Name
Centro de Imagem Diagnosticos SA
Chart & Performance
Profile
Centro de Imagem Diagnósticos S.A. provides diagnostic medicine services in Brazil. Its diagnostic medicine services include imaging diagnosis and chart-based diagnosis; nuclear medicine and cytology; pathological anatomy; and clinical tests. The company also engages in the provision of health consulting, advisory, courses and lectures, and the services related to health; management of chronic diseases; scientific and technologic research and development related to diagnostic medicine; preparation, issue, publication, and distribution of newspapers, books, magazines, periodicals, and other media for the dissemination of scientific knowledge; and grant and management of business franchises. Centro de Imagem Diagnósticos S.A. was founded in 1992 and is headquartered in São Paulo, Brazil.
Valuation
Title BRL in thousands, except ratios and share amounts | FY | FY | FY | FY | FY | FY | FY | FY | FY | FY |
---|---|---|---|---|---|---|---|---|---|---|
2023‑12 | 2022‑12 | 2021‑12 | 2020‑12 | 2019‑12 | 2018‑12 | 2017‑12 | 2016‑12 | 2015‑12 | 2014‑12 | |
Income | ||||||||||
Revenues | 1,179,584 8.72% | 1,085,009 -4.54% | 1,136,572 22.37% | |||||||
Cost of revenue | 1,139,859 | 1,097,675 | 1,042,464 | |||||||
Unusual Expense (Income) | ||||||||||
NOPBT | 39,725 | (12,666) | 94,108 | |||||||
NOPBT Margin | 3.37% | 8.28% | ||||||||
Operating Taxes | 19,090 | (13,991) | 468 | |||||||
Tax Rate | 48.06% | 0.50% | ||||||||
NOPAT | 20,635 | 1,325 | 93,640 | |||||||
Net income | (227,878) 3.94% | (219,243) -11,128.32% | 1,988 -102.15% | |||||||
Dividends | (1,884) | (2,003) | ||||||||
Dividend yield | 0.07% | 0.11% | ||||||||
Proceeds from repurchase of equity | 185,080 | (3,907) | (14,255) | |||||||
BB yield | -15.04% | 0.15% | 0.81% | |||||||
Debt | ||||||||||
Debt current | 407,035 | 424,490 | 366,556 | |||||||
Long-term debt | 1,166,169 | 1,178,781 | 967,914 | |||||||
Deferred revenue | ||||||||||
Other long-term liabilities | 81,296 | 78,200 | 68,794 | |||||||
Net debt | 1,346,952 | 1,375,643 | 1,199,957 | |||||||
Cash flow | ||||||||||
Cash from operating activities | 102,304 | 187,303 | 149,128 | |||||||
CAPEX | (91,520) | (113,009) | (100,493) | |||||||
Cash from investing activities | (111,150) | (142,496) | (105,698) | |||||||
Cash from financing activities | 8,697 | 196,846 | (145,207) | |||||||
FCF | (26,670) | 110,614 | 15,023 | |||||||
Balance | ||||||||||
Cash | 218,595 | 220,431 | 127,310 | |||||||
Long term investments | 7,657 | 7,197 | 7,203 | |||||||
Excess cash | 167,273 | 173,378 | 77,684 | |||||||
Stockholders' equity | 946,272 | 987,365 | 1,216,931 | |||||||
Invested Capital | 2,167,258 | 2,188,177 | 2,241,571 | |||||||
ROIC | 0.95% | 0.06% | 4.28% | |||||||
ROCE | 1.70% | 4.06% | ||||||||
EV | ||||||||||
Common stock shares outstanding | 118,293 | 117,815 | 117,548 | |||||||
Price | 10.40 -51.85% | 21.60 44.29% | 14.97 34.86% | |||||||
Market cap | 1,230,247 -51.66% | 2,544,804 44.62% | 1,759,694 34.31% | |||||||
EV | 2,603,735 | 3,952,668 | 2,993,793 | |||||||
EBITDA | 132,855 | 105,071 | 213,712 | |||||||
EV/EBITDA | 19.60 | 37.62 | 14.01 | |||||||
Interest | 246,997 | 151,483 | 84,320 | |||||||
Interest/NOPBT | 621.77% | 89.60% |